The measured conclusion is not that KLOW is necessarily dangerous, but that its safety is genuinely unknown, that at least one core component has been formally flagged for safety concerns, and that the blend, the dose, and the sourcing all add further uncharacterized risk
The key takeaway is that MEDVi itself does not prescribe medications
Important Notes Practical considerations for consistency, safety, and optimal outcomes
doi: 10.1002/glia.22558 139
82073429, 82273510, 82430101), Innovation Program of Shanghai Municipal Education Commission (No.2019-01-07-00-07-E00046), Clinical Research Plan of SHDC (No.2020CR1014B, 22022302, 2020CR6022), Shanghai Science and Technology Development Funds (24YF2738100)